EU-funded project develops mRNA vaccine targeting liver cancer
The European Innovation Council (EIC) is providing approximately €3.8 million in funding for the international research project ADVANCE, in which Universitätsmedizin Frankfurt is participating. The ADVANCE research team aims to develop an mRNA-based cancer vaccine for the treatment of hepatocellular carcinoma (HCC).
Read original article on The Medical News →Related news
-
Job-search app boosts employment rates and reduces depressive symptoms
United Kingdom
-
Swedish study identifies risk factors for prolonged opioid use after surgery
United Kingdom
-
School bullying tied to symptoms and diagnosis of PTSD
United Kingdom
-
Study examines long-term pain outcomes after surgical nerve freezing
United Kingdom
-
UCSF launches global study tracking real-world psychedelic experiences
United Kingdom
-
UCLA introduces single-port robotic approach for lung cancer surgery
United Kingdom
-
Clinical trial evaluates fully implantable cochlear implant technology
United Kingdom
-
Gradebooks outperform GPA in predicting adolescent substance use
United Kingdom